|
⚲
|
| Keyboard |
| Broder Samuel
✚
|
|
|---|---|
| CIK # | 0001340543 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001340543] | |
| 4 | [0001340543] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Faeth Therapeutics Inc | |
| Broder Samuel | |
| Orion Biotech Opportunities Corp | |
| Precigen Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2023-07-10 | Grant | 4,466 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2023-07-10 | Grant | 14,550 | $0.00 | |
|
Orion Biotech Opportunities Corp ORIA
Class B ordinary shares · derivative
|
2023-05-17 | Disposed to issuer | 40,000 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Common Stock
|
2022-06-10 | Grant | 4,466 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2022-06-10 | Grant | 14,550 | $0.00 | |
|
Faeth Therapeutics Inc SNSE
Stock Option (Right to Buy) · derivative
|
2021-02-03 | Grant | 16,666 | $0.00 | |
|
Precigen Inc XON
Option to Purchase Common Stock (Right to Buy) · derivative
|
2015-07-21 | Grant | 800,000 | $0.00 | |
|
Precigen Inc XON
Option to Purchase Common Stock (Right to Buy) · derivative
|
2014-03-20 | Grant | 100,000 | $0.00 |